Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases

Details for Australian Patent Application No. 2006214892 (hide)

Owner KT & G Co., Ltd MD Bioalpha Co., Ltd.

Inventors Jo, In Geun; Kwak, Taehwan; Yoo, Sang-Ku; Park, Myunggyu

Agent Davies Collison Cave

Pub. Number AU-A-2006214892

PCT Pub. Number WO2006/088315

Priority 10-2005-0012625 16.02.05 KR

Filing date 15 February 2006

Wipo publication date 24 August 2006

International Classifications

A61K 31/453 (2006.01)

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

2 August 2007 PCT application entered the National Phase

  PCT publication WO2006/088315 Priority application(s): WO2006/088315

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006214896-A method of allocating an internet protocol address in a broadband wireless access system

2006214879-Diamond tool